Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Adjuvant Treatment for Thymic Cancer With Completed Resection
NCT06402708Phase 3Recruiting
- Sponsor
- Fudan University
- Start
- Apr 2024
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, cisplatin, fluorouracil in thymic carcinoma (TC), sponsored by Fudan University. Started Apr 2024; status: recruiting.
02
Drugs
paclitaxelcisplatinfluorouracil
03
Conditions
thymic carcinoma (TC)
Beyond the preview
Go deeper on NCT06402708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06402708.